Anand Rotte
Regulatory Affairs, United States · United States
Editorial leadership for Journal of Dermatologic Research And Therapy ISSN 2471-2175
Research interests
- Cancer
- Melanoma
- Genomic Instability
- Reactive Oxygen Species
- Cell Signalling
Biography
Dr. Anand Rotte holds an M.Pharm. in Pharmacology from Kakatiya University, India, and a Ph.D. in Pharmacology from the University of Tuebingen, Germany. He is currently affiliated with Regulatory Affairs in the United States. Dr. Rotte has authored more than 19 indexed publications, with his research focusing on immunotherapy and oncology. His most-cited work, "Targeting TIGIT for Immunotherapy of Cancer: Update on Clinical Development" (2021), has received 64 citations, reflecting his contributions to advancing cancer immunotherapy strategies.
Selected publications
- Targeting TIGIT for Immunotherapy of Cancer: Update on Clinical Development 2021 cited 64×
- Pain relief and improvement in quality of life with 10 kHz SCS therapy: Summary of clinical evidence 2020 cited 49×
- Dose fractionation of CAR-T cells. A systematic review of clinical outcomes 2023 cited 40×
- 10-kHz Spinal Cord Stimulation Treatment for Painful Diabetic Neuropathy: Results from Post-Hoc Analysis of the SENZA-PPN Study 2020 cited 32×
- A Prospective, Multi‐Center, Clinical Trial of a 10‐kHz Spinal Cord Stimulation System in the Treatment of Chronic Pelvic Pain 2020 cited 31×
- Retrospective Analysis of Real-World Outcomes of 10 kHz SCS in Patients with Upper Limb and Neck Pain 2020 cited 25×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JDRT for your work?
This journal is guided by Anand Rotte (Regulatory Affairs, United States) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.